EpiPen Pricing Controversy Reveals Ignorance about Market Competition

by | Jun 26, 2018

EpiPen Pricing Controversy Reveals Ignorance about Market Competition

by | Jun 26, 2018

A recent episode of CNN’s Boss Files podcast featured Heather Bresch, CEO of Mylan and the first woman to run a Fortune 500 pharmaceutical company. The podcast focused primarily on her journey to success. However, roughly 40 minutes in, Bresch was questioned about her pricing strategy for EpiPen, the epinephrine auto-injector for treating emergency allergic reactions.
Mylan acquired the right to sell EpiPen in 2007 and, under Bresch’s leadership, EpiPen prices were raised nearly 400 percent in late 2015. In mid-2016, Mylan released a generic EpiPen, which sold for about $300 for a 2-pack (50 percent less expensive than the name-brand version). When questioned about Mylan’s pricing and promotion strategy, Bresch explained that patients “needed a solution and wanted a solution” and that her generic device provided both.
Not everyone is sympathetic to her answer. A recent business column in the Los Angeles Times called her comments “bogus on many levels” and said her actions demonstrate “unfettered corporate greed.” Others compare her to disgraced drug-industry executive Martin Shkreli of Turing Pharmaceuticals. Shkreli, who is now serving time for securities fraud, received sharp criticism when he raised the price of the drug Daraprim from $13.50 to $750 a pill in 2015.
Read the rest at independent.org.

Recent Articles

Recent

Down With Every War!

Down With Every War!

I'd like to say a word about a deceased friend. I don't remember how I met Murray Polner, but we were both academics on Long Island at the time. Our politics were not aligned. But we got along great. We decided to work on a project together: an anthology of the best...

read more
Rand Paul’s 2028 Pitch: Pro-Trade and Anti-War

Rand Paul’s 2028 Pitch: Pro-Trade and Anti-War

Neoconservatives and hawks of various stripes know why Republicans lost disastrously in the 2026 midterm elections: tariffs. They have a point. Polls did show that voter disapproval of President Donald Trump’s tariffs and other issues did help Democrats win big. But...

read more
Bureaucrats On the Road to War

Bureaucrats On the Road to War

The origins of the First World War are often explained through the familiar language of alliances, national interests, and the European balance of power. Yet, as I have previously argued, such explanations mistakenly treat governments as unitary actors, pursuing...

read more

Pin It on Pinterest

Share This